Physician profile
Jim Y Hsiang
NPI 1164531273
$258,259.90
in general payments reported to CMS, 2019-2025
30 companies · $30K in 2025
The $30K reported for 2025 was more than what 99% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49K · 2020: $17K · 2021: $22K · 2022: $40K · 2023: $76K · 2024: $24K · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $102K · Travel and Lodging: $22K · Food and Beverage: $4,320 · Consulting Fee: $908 · Education: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $101,813.01 |
| Travel and Lodging | $22,322.18 |
| Food and Beverage | $4,320.20 |
| Consulting Fee | $908.00 |
| Education | $175.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $114,814.85 | 2019-2025 | Provenge |
| Astellas Pharma US INC | $96,604.92 | 2019-2025 | Xtandi |
| Amgen INC. | $22,857.01 | 2019-2024 | Evenity, Prolia |
| Astellas Pharma Global Development | $7,810.44 | 2019 | |
| Janssen Biotech, INC. | $5,019.14 | 2019-2025 | Erleada, Akeega, Balversa |
| Pfizer INC. | $4,956.66 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $2,612.66 | 2019-2025 | |
| Boston Scientific Corporation | $1,505.83 | 2019-2025 | Spaceoar Vue System - 10ml, Spaceoar System |
| Astrazeneca Pharmaceuticals Lp | $306.42 | 2019-2022 | |
| Blue Earth Diagnostics | $256.66 | 2019-2024 | |
| Myriad Genetic Laboratories, INC. | $223.72 | 2020-2024 | Bracanalysis Cdx |
| Merck Sharp & Dohme LLC | $211.24 | 2021-2024 | Keytruda, Lynparza |
| Novartis Pharmaceuticals Corporation | $167.96 | 2023-2025 | |
| Myovant Sciences INC. | $136.13 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $123.87 | 2023 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $106.78 | 2023 | Truebeam |
| Sumitomo Pharma America, INC. | $79.01 | 2023-2024 | Orgovyx |
| Seagen INC. | $75.99 | 2025 | |
| Caris Mpi, INC. | $68.94 | 2025 | Mi Cancer Seek |
| Radius Health, INC. | $55.58 | 2020 | |
| Foundation Medicine, INC. | $43.34 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $42.20 | 2022-2024 | |
| Palette Life Sciences, INC. | $36.70 | 2022 | |
| Clovis Oncology, INC. | $32.10 | 2021 | |
| Teleflex LLC | $22.62 | 2025 | Barrigel |
| Telix Pharmaceuticals | $21.93 | 2023 | Illuccix |
| Kowa Pharmaceuticals America, INC. | $19.75 | 2022 | |
| Sun Pharmaceutical Industries INC. | $19.48 | 2022 | |
| Urovant Sciences INC | $19.43 | 2022 | |
| Janssen Pharmaceuticals, INC | $8.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jim Hsiang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.